Neoplasms, Hematologic Completed Phase 2 Trials for Darinaparsin (DB06179)

Also known as: Hematologic Neoplasm / Hematologic Neoplasms

IndicationStatusPhase
DBCOND0056760 (Neoplasms, Hematologic)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00421213Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow CancersTreatment